November 9, 3:45 PM
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500 also fell, dropping, 0.80% to 4,347.67.
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
November 9, 2:13 PM
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
November 9, 1:31 PM
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 156.6% to $0.58 during Thursday’s regular session. Trading volume for…
November 9, 1:01 PM
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53. The S&P 500 also rose, gaining, 0.16% to 4,389.61.
November 9, 10:43 AM
U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Following the market opening Thursday, the Dow traded down 0.02% to 34,105.13 while the NASDAQ rose 0.01% to 13,651.18. The S&P 500 also fell, dropping, 0.01% to 4,382.36.
November 9, 10:29 AM
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results.
November 9, 9:09 AM
Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint of confirmed disability improvement (CDI) by expanded disabi
November 9, 9:06 AM
Gainers Intelligent Bio Solutions (NASDAQ:INBS) shares increased by 72.0% to $0.39 during Thursday’s pre-market session. The market value…
Atara Biotherapeutics Announces Primary Analysis Data From Phase 2 EMBOLD Clinical Trial Of ATA188 In Non-Active Progressive Multiple Sclerosis; Primary Endpoint Of Confirmed Disability Improvement At 12 Months Not Achieved
November 8, 7:04 PM
Primary Endpoint of Confirmed Disability Improvement at 12 Months Not AchievedCompany to Further Analyze Data and Evaluate Strategic Options for ATA188 Program with Focusing of Resources and Planned Expense Reductions